Aristea Therapeutics

Developer of small molecule based therapeutics for inflammatory diseases

placeSan Diego, California, United States calendar_todayFounded 2018 groups10 employees language aristeatx.com

Innovation

3 patent families — focus: Human necessities; filing pace slowing. Cited 16 times.

YearFilings
20211
20223
20231

Investor mix

4 investors on record; lead investors include Fidelity Investments.

Investor typeCountShare
Other / undisclosed4100%
Coming soon